Technology
Health
Biotechnology

Ascendis Pharma

$116.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.06 (-1.73%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ASND and other stocks, options, ETFs, and crypto commission-free!

About ASND

Ascendis Pharma A/S American Depositary Shares, also called Ascendis Pharma, is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. Read More The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Employees
Headquarters
Hellerup, Capital Region
Founded
2006
Market Cap
5.58B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
238.40K
High Today
$120.24
Low Today
$115.85
Open Price
$119.11
Volume
170.18K
52 Week High
$133.96
52 Week Low
$53.21

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
Europe (Non-UK)
Europe

ASND Earnings

-$1.38
-$1.13
-$0.89
-$0.64
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 28, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.